The tumor microenvironment: A critical determinant of neoplastic evolution

European Journal of Cell Biology

Volumn 82, Issue 11, 2003, Pages 539-548

  van Kempen, Léon C L T ^a   Ruiter, Dirk J ^a   van Muijen, Goos N P ^a   Coussens, Lisa M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cutaneous melanoma; Cutaneous squamous cell carcinoma; Fibroblast; Inflammation; Tumor microenvironment

Indexed keywords

AUTACOID; BASIC FIBROBLAST GROWTH FACTOR; CD147 ANTIGEN; CELL PROTEIN; CHEMOKINE; COLLAGEN TYPE 1; CYTOKINE; EPIDERMAL GROWTH FACTOR; GELATINASE B; MACROPHAGE ELASTASE; MATRIX PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL COLLAGENASE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

APOPTOSIS; CARCINOGENESIS; COLLAGEN METABOLISM; DIPLOIDY; FIBROBLAST; HOMEOSTASIS; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MELANOMA; METASTASIS; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR GROWTH; TUMOR MODEL;

EID: 0348149012     PISSN: 01719335     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-9335-00346     Document Type: Article

References (105)

1. Abe, M., Kurosawa, M., Ishikawa, O., Miyachi, Y., Kido, H. (1998): Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production. Clin. Exp. Allergy 28, 1509-1517.
2. Airola, K., Johansson, N., Kariniemi, A. L., Kahari, V. M., Saarialho-Kere, U. K. (1997): Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J. Invest. Dermatol. 109, 225-231.
3. Airola, K., Karonen, T., Vaalamo, M., Lehti, K., Lohi, J., Kariniemi, A. L., Keski-Oja, J., Saarialho-Kere, U. K. (1999): Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br. J. Cancer 80, 733-743.
4. Balkwill, F., Mantovani, A. (2001): Inflammation and cancer: back to Virchow? Lancet 357, 539-545.
5. Balmain, A., Gray, J., Ponder, B. (2003): The genetics and genomics of cancer. Nat. Genet. 33, Suppl., 238-244.
6. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., Hanahan, D. (2000): Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744.
7. Bergers, G., Coussens, L. M. (2000): Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr. Opin. Genet. Dev. 10, 120-127.
8. Berking, C., Takemoto, R., Schaider, H., Showe, L., Satyamoorthy, K., Robbins, P., Herlyn, M. (2001): Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Cancer Res. 61, 8306-8316.
9. Berndt, A., Borsi, L., Hyckel, P., Kosmehl, H. (2001): Fibrillary codeposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro. J. Cancer Res. Clin. Oncol. 127, 286-292.
10. Bingle, L., Brown, N. J., Lewis, C. E. (2002): The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
11. Birchmeier, W. (1995): E-cadherin as a tumor (invasion) suppressor gene. Bioessays 17, 97-99.
12. Bissell, M. J., Radisky, D. (2001): Putting tumours in context. Nat. Rev. Cancer 1, 46-54.
13. Blasi, F., Carmeliet, P. (2002): uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3, 932-943.
14. Bodmer, D., van den Hurk, W., van Groningen, J. J., Eleveld, M. J., Martens, G. J., Weterman, M. A., van Kessel, A. G. (2002): Understanding familial and non-familial renal cell cancer Hum. Mol. Genet. 11, 2489-2498.
15. Bodey, B., Bodey, B. Jr., Siegel, S. E., Kaiser, H. E. (2001): Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis. In Vivo 15, 57-64.
16. Brocker, E. B., Zwadlo, G., Suter, L., Brune, M., Sorg, C. (1987): Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype. Cancer Immunol. Immunother. 25, 81-86.
17. Cairns, J. A., Walls, A. F. (1997): Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest. 99, 1313-1321.
18. Carmeliet, P. (2003): Angiogenesis in health and disease. Nat. Med. 9, 653-660.
19. Clarijs, R., Schalkwijk, L., Ruiter, D. J., de Waal, R. M. (2001): Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 42, 1422-1428.
20. Clarijs, R., Otte-Holler, I., Ruiter, D. J., de Waal, R. M. (2002): Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest. Ophthalmol. Vis. Sci. 43, 912-918.
21. Clarijs, R., Ruiter, D. J., De Waal, R. M. (2003): Pathophysiological implications of stroma pattern formation in uveal melanoma. J. Cell. Physiol. 194, 267-271.
22. Claudatus, J. C. Jr., d'Ovidio, R., Lospalluti, M., Meneghini, C. L. (1986): Skin tumors and reactive cellular infiltrate: further studies. Acta Derm. Venereol. 66, 29-34.
23. Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., Hanahan, D. (1999): Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13, 1382-1397.
24. Coussens, L. M., Tinkle, C. L., Hanahan, D., Werb, Z. (2000): MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490.
25. Coussens, L. M., Werb, Z. (2002): Inflammation and cancer. Nature 420, 860-867.
26. Coussens, L. M., Fingleton, B., Matrisian, L. M. (2002): Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392.
27. Dano, K., Romer, J., Nielsen, B. S., Bjorn, S., Pyke, C., Rygaard, J., Lund, L. R. (1999): Cancer invasion and tissue remodeling - cooperation of protease systems and cell types. APMIS 107, 120-127.
28. Dhawan, P., Richmond, A. (2002): Role of CXCL1 in tumorigenesis of melanoma. J. Leukoc. Biol. 72, 9-18.
29. Di Lullo, G. A., Sweeney, S. M., Korkko, J., Ala-Kokko, L., San Antonio, J. D. (2002): Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J. Biol. Chem. 277, 4223-4231.
30. Dvorak, A. M., Mihm, M. C. Jr., Osage, J. E., Dvorak, H. F. (1980): Melanoma. An ultrastructural study of the host inflammatory and vascular responses. J. Invest. Dermatol. 75, 388-393.
31. Dvorak, H. F. (1986): Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659.
32. Egeblad, M., Werb, Z. (2002): New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
33. Elkin, M., Miao, H. Q., Nagler, A., Aingorn, E., Reich, R., Hemo, I., Dou, H. L., Pines, M., Vlodavsky, I. (2000): Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J. 14, 2477-2485.
34. Elpek, G. O., Gelen, T., Aksoy, N. H., Erdogan, A., Dertsiz, L., Demircan, A., Keles, N. (2001): The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J. Clin. Pathol. 54, 940-944.
35. Fang, K. C., Raymond, W. W., Blount, J. L., Caughey, G. H. (1997): Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J. Biol. Chem. 272, 25628-25635.
36. Fearon, E. R., Vogelstein, B. (1990): A genetic model for colorectal tumourigenesis. Cell 61, 759-767.
37. Flynn, E. A., Schwartz, J. L., Shklar, G. (1991): Sequential mast cell infiltration and degranulation during experimental carcinogenesis. J. Cancer Res. Clin. Oncol. 117, 115-122.
38. Friedl, P., Wolf, K. (2003): Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362-374.
39. Frungieri, M. B., Weidinger, S., Meineke, V., Kohn, F. M., Mayerhofer, A. (2002): Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARgamma: Possible relevance to human fibrotic disorders. Proc. Natl. Acad. Sci. USA 99, 15072-15077.
40. Gavish, Z., Pinthus, J. H., Barak, V., Ramon, J., Nagler, A., Eshhar, Z., Pines M. (2002): Growth inhibition of prostate cancer xenografts by halofuginone. Prostate 51, 73-83.
41. Gharaee-Kermani, M., Phan, S. H. (2001): Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr. Pharm. Des. 7, 1083-1103.
42. Ghosh, A. K., Yuan, W., Mori, Y., Chen, S. J., Varga, J. (2001): Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β. Integration at the level of p300/CBP transcriptional coactivators. J. Biol. Chem. 276, 11041-11048.
43. Giambernardi, T. A., Sakaguchi, A. Y., Gluhak, J., Pavlin, D., Troyer, D. A., Das, G., Rodeck, U., Klebe, R. J. (2001): Neutrophil collagenase (MMP-8) is expressed during early development in neural crest cells as well as in adult melanoma cells. Matrix Biol. 20, 577-587.
44. Gustafsson, E., Fassler, R. (2000): Insights into extracellular matrix functions from mutant mouse models. Exp. Cell Res. 261, 52-68.
45. Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., Kalluri, R. (2003): Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alpha Vbeta3 integrin. Cancer Cell 3, 589-601.
46. Hanahan, D., Weinberg, R. A. (2000): The hallmarks of cancer. Cell 100, 57-70.
47. Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., McDonald, D. M. (2000): Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156, 1363-1380.
48. Hasty, K. A., Pourmotabbed, T., Goldberg, G. I., Mainardi, C. L., Spinella, D. G., Stevens, R. M. (1990): Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J. Biol. Chem. 265, 11421-11424.
49. Hendrix, M. J., Seftor, E. A., Hess, A. R., Seftor, R. E. (2003): Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer 3, 411-421.
50. Hiromatsu, Y., Toda, S. (2003): Mast cells and angiogenesis. Microsc. Res. Tech. 60, 64-69.
51. Hofmann, U. B., Westphal, J. R., Van Muijen, G. N., Ruiter, D. J. (2000): Matrix metalloproteinases in human melanoma. J. Invest. Dermatol. 115, 337-344.
52. Holleran, W. M., Galardy, R. E., Gao, W. N., Levy, D., Tang, P. C., Elias, P. M. (1997): Matrix metalloproteinase inhibitors reduce phorbol ester-induced cutaneous inflammation and hyperplasia. Arch. Dermatol. Res. 289, 138-144.
53. Hsu, M.-Y., Meier, F., Herlyn, M. (2002): Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70, 522-536.
54. Huang, S., Ullrich, S. E., Bar-Eli, M. (1999): Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J. Interferon Cytokine Res. 19, 697-703.
55. Iamaroon, A., Pongsiriwet, S., Jittidecharaks, S., Pattanaporn, K., Prapayasatok, S., Wanachantararak, S. (2003): Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J. Oral Pathol. Med. 32, 195-199.
56. Inagaki, Y., Nemoto, T., Kushida, M., Sheng, Y., Higashi, K., Ikeda, K., Kawada, N., Shirasaki, F., Takehara, K., Sugiyama, K., Fujii, M., Yamauchi, H., Nakao, A., De Crombrugghe, B., Watanabe, T., Okazaki, I. (2003): Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 38, 890-899.
57. Jackson, C. J., Jenkins, K. L. (1991): Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium. Exp. Cell Res. 192, 319-323.
58. Jaenisch, R., Bird, A. (2003): Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33, Suppl., 245-254.
59. Jussila, T., Kauppila, S., Risteli, L., Risteli, J., Stenback, F. (2002): Collagen formation in extracellular matrix of transplants of human transformed keratinocyte cell lines. Anticancer Res. 22, 1705-1711.
60. Kalluri, R. (2003): Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3, 422-433.
61. Kanbe, N., Tanaka, A., Kanbe, M., Itakura, A., Kurosawa, M., Matsuda, H. (1999): Human mast cells produce matrix metalloproteinase 9. Eur. J. Immunol. 29, 2645-2649.
62. Kerkela, E., Ala-Aho, R., Jeskanen, L., Rechardt, O., Grenman, R., Shapiro, S. D., Kahari, V. M., Saarialho-Kere, U. (2000): Expression of human macrophage metalloelastase (MMP-12) by tumor cells in skin cancer. J. Invest. Dermatol. 114, 1113-1119.
63. Kerkela, E., Ala-Aho, R., Lohi, J., Grenman, R., M-Kahari, V., Saarialho-Kere, U. (2001): Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br. J. Cancer 84, 659-669.
64. Kielty, C. M., Hopkinson, I., Grant, ME (1993): The collagen family: Structure, assembly, and organization in the extracellular matrix. In: P. M. Royce and B. Steinmann (eds.): Connective Tissue and Its Hereditable Disorders. Wiley-Liss, New York, pp. 103-147.
65. Knudson, A. G. (2001): Two genetic hits (more or less) to cancer. Nat. Rev. Cancer 1, 157-162.
66. Li, J., Zhang, Y. P., Kirsner, R. S. (2003): Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60, 107-114.
67. Lin, E. Y., Gouon-Evans, V., Nguyen, A. V., Pollard, J. W. (2002): The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J. Mammary Gland Biol. Neoplasia 7, 147-162.
68. Lynch, C. C., Matrisian, L. M. (2002): Matrix metalloproteinases in tumor-host cell communication. Differentiation 70, 561-573.
69. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002): Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
70. Martin, P. (1997): Wound healing-aiming for perfect skin regeneration. Science 276, 75-81.
71. McGaha, T., Kodera, T., Phelps, R., Spiera, H., Pines, M., Bona, C. (2002): Effect of halofuginone on the development of tight skin (TSK) syndrome. Autoimmunity 35, 277-282.
72. Meier, F., Satyamoorthy, K., Nesbit, M., Hsu, M. Y., Schittek, B., Garbe, C., Herlyn, M. (1998): Molecular events in melanoma development and progression. Front. Biosci. 3, D1005-1010.
73. Nagase, H. (1997): Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151-160.
74. Nesbit, M., Schaider, H., Miller, T. H., Herlyn, M. (2001): Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J. Immunol. 166, 6483-6490.
75. Norrby, K. (2002): Mast cells and angiogenesis. APMIS 110, 355-371.
76. Olsen, L, Sherratt, J. A., Maini, P. K., Arnold, F. (1997): A mathematical model for the capillary endothelial cell-extracellular matrix interactions in wound-healing angiogenesis. IMA J. Math. Appl. Med. Biol. 14, 261-281.
77. Ono, M., Torisu, H., Fukushi, J., Nishie, A., Kuwano, M. (1999): Biological implications of macrophage infiltration in human tumor angiogenesis. Cancer Chemother. Pharmacol. 43, Suppl., S69-S71.
78. Oxford, G., Theodorescu, D. (2003): Ras superfamily monomeric G proteins in carcinoma cell motility. Cancer Lett. 189, 117-128.
79. Pyke, C., Ralfkiaer, E., Huhtala, P., Hurskainen, T., Dano, K., Tryggvason, K. (1992): Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res. 52, 1336-1341.
80. Riches, D. W. H. (1996): Macrophage involvement in wound repair, remodeling and fibrosis. In: R. A. F. Clark, (ed.): The Molecular and Cellular Biology of Wound Repair. Plenum New York, London, 2nd ed., pp. 95-141.
81. Ruiter, D., Bogenrieder, T., Elder, D., Herlyn, M. (2002): Melanomastroma interactions: structural and functional aspects. Lancet Oncol. 3, 35-43.
82. Sahai, E., Marshall, C. J. (2003): Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat. Cell Biol. 5, 711-719.
83. Schoppmann, S. F., Birner, P., Stockl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., Kerjaschki, D. (2002): Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 161, 947-956.
84. Seandel, M., Noack-Kunnmann, K., Zhu, D., Aimes, R. T., Quigley, J. P. (2001): Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Blood 97, 2323-2332.
85. Shapiro, S. D., Kobayashi, D. K., Ley, T. J. (1993): Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268, 23824-23829.
86. Sica, A., Saccani, A., Mantovani, A. (2002): Tumor-associated macrophages: a molecular perspective. Int. Immunopharmacol. 2, 1045-1054.
87. Skobe, M., Hamberg, L. M., Hawighorst, T., Schirner, M., Wolf, G. L., Alitalo, K., Detmar, M. (2001): Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am. J. Pathol. 159, 893-903.
88. Spira, G., Mawasi, N., Paizi, M., Anbinder, N., Genina, O., Alexiev, R., Pines, M. (2002): Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats. J. Hepatol. 37, 331-339.
89. Stamenkovic I. (2000): Matrix metalloproteinases in tumor invasion and metastasis. Semin. Cancer Biol. 10, 415-433.
90. Stamenkovic I. (2003): Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol. 200, 448-464.
91. Sternlicht, M. D., Werb, Z. (2001): How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
92. Thewes, M., Worret, W. I., Engst, R., Ring, J. (1999): Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders. Clin. Exp. Dermatol. 24, 122-126.
93. Toth-Jakatics, R., Jimi, S., Takebayashi, S., Kawamoto, N. (2000): Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum. Pathol. 31, 955-960.
94. Tsukifuji, R., Tagawa, K., Hatamochi, A., Shinkai, H. (1999): Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis. Br. J. Cancer 80, 1087-1091.
95. Tuckwell, D. (2002): Identification and analysis of collagen alpha 1(XXI), a novel member of the FACIT collagen family. Matrix Biol. 21, 63-66.
96. Uitto, J., Kouba, D. (2000): Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J. Dermatol. Sci. 24, Suppl. 1, S60-S69.
97. Van Kempen, L. C., Rhee, J. S., Dehne, K., Lee, J., Edwards, D. R., Coussens, L. M. (2002): Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. Differentiation 70, 610-623.
98. Varney, M. L., Olsen, K. J., Mosley, R. L., Bucana, C. D., Talmadge, J. E., Singh, R. K. (2002): Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo 16, 471-477.
99. Vesey, D. A., Cheung, C., Cuttle, L., Endre, Z., Gobe, G., Johnson, D. W. (2002): Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. J. Lab. Clin. Med. 140, 342-350.
100. Vuorio, E., de Crombrugghe, B. (1990): The family of collagen genes. Annu. Rev. Biochem. 59, 837-872.
101. Westermarck, J., Kahari, V. M. (1999): Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792.
102. Wilson, K. (1997): Wound healing: the role of macrophages. Nurs. Crit. Care 2, 291-296.
103. Witte, M. B., Barbul, A. (2002): Role of nitric oxide in wound repair. Am. J. Surg. 183, 406-412.
104. Yong, L. C. (1997): The mast cell: Origin, morphology, distribution, and function. Exp. Toxicol. Pathol. 49, 409-424.
105. Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H., Kuwano, M. (1997): Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis. Mol. Cell. Biol. 17, 4015-4023.